Respiratory news

High prescribing of short-acting reliever inhalers 'suggests asthma guidance not being followed'

High prescribing of short-acting reliever inhalers 'suggests asthma guidance not being followed'

Frequent prescribing of short-acting ß2 agonists (SABA)...

Stepping down of asthma treatment 'worryingly infrequent' despite clinical and cost benefits

Stepping down of asthma treatment 'worryingly infrequent' despite clinical and cost benefits

Asthma guidelines recommend stepping down of medication...

Delayed antibiotic prescribing for URTIs increases hospital admission risk, study shows

Delayed antibiotic prescribing for URTIs increases hospital admission risk, study shows

Delaying the prescription of antibiotics in patients...

MIMS launches Respiratory and Allergy Learning webinars

MIMS launches Respiratory and Allergy Learning webinars

Join us for the 2020 Respiratory and Allergy Learning...

NICE releases rapid guidance for primary care clinicians during COVID-19 pandemic

NICE releases rapid guidance for primary care clinicians during COVID-19 pandemic

New guidance on the care of patients with suspected...

Inhaler prescribing guidance issued as spike in demand causes shortages

Inhaler prescribing guidance issued as spike in demand causes shortages

Prescribers have been urged not to extend repeat prescription...

NICE overturns advice to increase steroid dose in children with asthma

NICE overturns advice to increase steroid dose in children with asthma

NICE has withdrawn its recommendation to quadruple...

Free respiratory and allergy workshops announced

Free respiratory and allergy workshops announced

The MIMS Workshops Respiratory and Allergy Learning...

PHE issues coronavirus guidance for primary care

PHE issues coronavirus guidance for primary care

Public Health England (PHE) has issued guidance for...

Triple therapy 'potentially best option' for stable COPD patients

Triple therapy 'potentially best option' for stable COPD patients

Triple therapy with a long-acting muscarinic antagonist...

MHRA advises prescribers to consider carefully the benefits and neuropsychiatric risks of montelukast

MHRA advises prescribers to consider carefully the benefits and neuropsychiatric risks of montelukast

Prescribers should be alert for possible neuropsychiatric...

New antibiotic prescribing guidance issued for pneumonia

New antibiotic prescribing guidance issued for pneumonia

NICE has published antimicrobial prescribing guidelines...

MIMS summary of NICE COPD guidance updated

MIMS summary of NICE COPD guidance updated

Prescribers can now consult the quick-reference MIMS...

Soft-mist inhaler now available as reusable device

Soft-mist inhaler now available as reusable device

Respimat is now available as a reusable inhaler that...

New egg-free flu vaccine for 2019/20 season

New egg-free flu vaccine for 2019/20 season

MIMS flu vaccine listings have been updated to reflect...

Updated BTS/SIGN asthma guidance recommends quadrupling inhaled steroid dose to treat an attack

Updated BTS/SIGN asthma guidance recommends quadrupling inhaled steroid dose to treat an attack

Healthcare professionals should consider quadrupling...

Two new steroid inhalers launched

Two new steroid inhalers launched

A new beclometasone metered-dose inhaler and a new...

Quick-reference MIMS COPD prescribing resources updated

Quick-reference MIMS COPD prescribing resources updated

Concise MIMS resources on COPD management and antibiotic...

Compare COPD inhalers and insulin pens with new MIMS tables

Compare COPD inhalers and insulin pens with new MIMS tables

Quick-reference comparison charts for COPD combination...

Widespread false diagnosis of COPD is exposing patients to unnecessary medication risks, study suggests

Widespread false diagnosis of COPD is exposing patients to unnecessary medication risks, study suggests

Patients are being unnecessarily exposed to the adverse...